Salona Global Medical Device Corporation Launches Expansion of Sales Organization; Releases Investor Presentation

SAN DIEGO, April 04, 2022 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (“Salona” or the ‎‎“Company”) (TSXV:SGMD), ‎an acquisition-oriented medical device company serving the global injury and surgery recovery (known as recovery science) market, announced today it had launched the expansion of its sales organization as a result of accelerating its operational integration. As part of the launch, Salona has hired Scott Rogow, a senior sales executive with over 30 years of experience in the recovery science industry primarily serving as former Director of Business Development at DJO Global, as Vice-President of Sales and Marketing.

The latest investor presentation has been posted on the Company’s website in advance of institutional investor presentations. The updated presentation will be available at: www.salonaglobal.com/downloads.

“I am glad to be working with Scott Rogow again,” said Les Cross, Chairman of Salona. “He was a strong clinical sales leader when he worked for me previously and I expect he will build an aggressive nationwide sales team for Salona Global. As we add additional products to our line up, either through acquisition, IP in-licensing, distribution contracts, or through development and refining of products in-house, Scott will lead our organic growth efforts across all channels.”

For more information please contact:

Les Cross 
Chairman of the Board and Interim Chief Executive Officer 
Tel: [phone] 
Email: [e-mail]

Additional Information

There can be no assurance that any acquisition will ‎be completed or the timing of any acquisitions. Completion of any transaction will be subject to ‎applicable ‎director, shareholder ‎and regulatory approvals.‎

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

Certain statements contained in this press release constitute "forward-looking information" within the meaning of the Private Securities Litigation Reform Act of 1995 and applicable Canadian securities laws. These statements can be identified by the use of forward-looking terminology such as “expects” “believes”, “estimates”, "may", "would", "could", ‎‎"should", "potential", ‎‎‎‎‎"will", "seek", "intend", "plan", and "anticipate", and similar expressions as they relate ‎‎‎‎to the Company, including: Salona expecting Mr. Rogow will build an aggressive nationwide sales team for Salona; and Salona adding additional ‎products to its lineup. All ‎statements ‎other than ‎statements of ‎historical fact may be forward-‎looking ‎information. Such statements reflect the Company's current views and intentions with respect to future ‎events, and current information available to the Company, and are subject to certain risks, ‎uncertainties and assumptions, including: Mr. Rogow being successful in identifying and ultimately retaining talent and the Company having the necessary capital to fund a nationwide sales team; and the Company identifying and successfully executing on the development or acquisition, marketing, and sale of new products.. Salona cautions that the forward-looking statements contained herein are qualified by important factors that could cause actual results to differ materially from those reflected by such statements. Such factors include but are not limited to the ‎‎general business and ‎‎economic ‎conditions in the regions in ‎which Salona operates; the ability of Salona to execute on key ‎‎priorities, ‎including the successful completion of acquisitions, business ‎retention, and ‎‎strategic plans and to ‎‎attract, develop ‎and retain key executives; difficulty integrating newly acquired businesses; ‎‎the ability to ‎‎‎implement business ‎strategies and pursue business opportunities; ‎‎disruptions in or ‎‎attacks (including ‎cyber-attacks) on Salona’s information ‎technology, internet, network ‎‎access or other ‎‎voice or data ‎communications systems or services; the evolution of various types of fraud or other ‎‎‎criminal ‎‎behavior to which ‎Salona is exposed; the failure of third parties to comply with their obligations to ‎‎Salona or its ‎affiliates; the ‎impact of new and changes to, or application of, current laws and regulations; ‎granting of permits and licenses in a highly regulated business; the ‎overall difficult ‎‎‎‎‎litigation environment, including in the United States; increased competition; changes in foreign currency rates; ‎increased ‎‎‎‎funding ‎costs and market volatility due to market illiquidity and competition for funding; the ‎availability of funds ‎‎‎‎and resources to pursue operations; critical ‎accounting estimates and changes to accounting ‎standards, policies, ‎‎‎‎and methods used by Salona; the occurrence of natural and unnatural ‎‎catastrophic ‎events ‎and claims ‎‎‎‎resulting from such events; and risks related to COVID-19 including various ‎recommendations, ‎orders ‎and ‎‎‎measures ‎of governmental ‎authorities ‎to try to limit the pandemic, including travel ‎restrictions, border ‎closures, ‎‎‎‎non-essential business ‎closures, ‎quarantines, ‎self-isolations, shelters-in-place and ‎social distancing, ‎disruptions ‎‎‎to ‎markets, economic ‎activity, ‎financing, supply chains and sales channels, and a ‎‎deterioration of ‎general ‎‎‎economic ‎conditions ‎including a ‎possible national or global recession‎; as well as those ‎risk factors ‎discussed or ‎‎‎referred to in Salona’s disclosure ‎documents filed with United States Securities and ‎Exchange ‎Commission and available at www.sec.gov, and with the securities regulatory authorities in certain ‎provinces of ‎Canada and available at www.sedar.com. Should any factor affect Salona in an unexpected ‎‎‎manner, ‎or ‎should ‎assumptions ‎underlying the forward-looking information prove incorrect, the actual results or ‎‎‎events ‎may ‎differ ‎materially ‎from the results or events predicted. Any such forward-looking information is ‎‎‎expressly ‎qualified ‎in its ‎entirety by ‎this cautionary statement. Moreover, Salona does not assume ‎‎‎responsibility for the ‎‎accuracy or ‎‎completeness of such forward-looking information. The forward-looking ‎‎‎information included in the ‎investor call ‎is ‎made as of the date of the investor call and Salona undertakes ‎‎‎no obligation to publicly ‎update or ‎revise ‎any ‎forward-looking information, other than as required by applicable ‎‎‎law.‎

Preliminary Financial Metrics

This press release contains certain pre-released fourth quarter financial metrics. The fourth quarter financial metrics contained in this press release are preliminary and represent the most current information available to the Company's management, as financial closing procedures for the fourth quarter ended February 28, 2022 are not yet complete. The Company's actual consolidated audited financial statements for such period may result in material changes to the financial metrics summarized in this press release (including by any one financial metric, or all of the financial metrics, being below or above the figures indicated) as a result of the completion of normal quarter and year end accounting procedures and adjustments, and also what one might expect to be in the final consolidated financial statements based on the financial metrics summarized in this press release. Although the Company believes the expectations reflected in this press release are based upon reasonable assumptions, the Company can give no assurance that actual results will not differ materially from these expectations.

 

Source: Salona Global Medical Device Corporation

2022 GlobeNewswire, Inc., source Press Releases - Canada